NEW YORK (GenomeWeb) – Merck KGaA today said that it will collaborate with Sysmex Inostics on the development of a RAS biomarker mutation test for metastatic colorectal cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.
In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.
South African researchers uncover bone cancer in an ancient hominin ancestor.
English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.